Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

2. Molecular origins — gastric BPC vs thymosin beta-4

BPC-157 is a synthetic pentadecapeptide (15 amino acids) with sequence GEPPPGKPADDAGLV. It is derived from a fragment of the human gastric juice protein Body Protection Compound, identified and characterised primarily by the Sikirić research group at the Unive

This comparison does not assign a generated winner or score.

  • BPC-157 is a synthetic pentadecapeptide (15 amino acids) with sequence GEPPPGKPADDAGLV. It is derived from a fragment of the human gastric juice protein Body Protection Compound, identified and characterised primarily by the Sikirić research group at the University of Zagreb.
  • TB-500 is a synthetic peptide based on the active region of thymosin beta-4 (TB-4), a 43-amino-acid naturally occurring peptide expressed in most mammalian cells. TB-500 is typically sold as a 17-amino-acid peptide encompassing the biologically active region (residues 17-23) responsible for actin binding, and can refer to either the N-acetylated LKKTETQ heptapeptide core or longer sequences surrounding this core.
  • The origins are biologically quite different: BPC is a gut-protective fragment of stomach protein; TB-4 is an intracellular actin-sequestering peptide expressed broadly across tissues.
More references

Related material

Comparison

BPC-157 vs TB-500

BPC-157 vs TB-500 A 2026 UK research comparison of BPC-157 and TB-500 — two distinct peptides with overlapping preclinical evidence in tendon, ligament and muscle repair. Mechanis…

View details →
Comparison

BPC-157 vs TB-500

Last updated: April 2026 · UK research-grade reference · For laboratory research use only — not for human consumption

View details →
Comparison

3. Mechanism comparison

BPC-157 mechanism (primary axes): VEGFR2 activation → angiogenesis FAK-paxillin pathway → fibroblast migration Nitric oxide system modulation EGR1 pathway engagement Protection ag…

View details →